Introduction
The discovery of the first fullerene compound C60 is a pivotal moment in modern chemistry (1) .
Not only was it the discovery of a new form of elemental carbon, it also provided the archetype linkage between the molecular and nano regimes. No sooner was the discovery published than a plethora of researchers initiated studies of the physical and chemical properties of C60, as well as its higher homologs (e.g., C70), but also its elongated relatives (carbon nanotubes) (2) . One feature of these materials that was quickly apparent was their extreme hydrophobic nature (3), which suggested limited biological implications due to the restricted transport in aqueous solution (4) . However, it was this same hydrophobicity coupled with the electrochemical behaviour (5) that offered an interesting potential for interactions with biological systems (6, 7, 8) .
Initial studies of the biological activity of fullerenes involved functionalization designed to enhance the solubility (7, 9) , which involved chemical substituents with acid or basic groups to allow either the formation of charged species in water at relevant pH or enhanced hydrogen bonding (10) . A logical extension of this approach was the formation of zwitter ionic functionality, and it is here that amino acid moiety represents a flexible solution to solubility and functionality. The presence of potentially both positive (-NH3 + ) and negative (-CO2   -) functionality offers compatibility in aqueous solutions over a range of pH and ionic concentration, while the inherent chemical functionality allows for their use as synthons to create larger structures. The first amino acid derivative of C60 was reported in 1993 (11) , and since that time [60]fullerene amino acids have been prepared with a variety of linkage units (12) (13) (14) (15) (16) . Figure 1 shows an idealized structure of a C60-amino acid, where the linkage unit may or may not be either structurally related to a known amino acid, and can vary in its flexibility and length. The topic of [60] fullerene amino acids has been reviewed (17, 18) .
Given the composition of a peptide is a polymer of various amino acids, one obvious application of [60] fullerene-based amino acids is their incorporation into a peptide chain. The resulting [60]fullerene-peptide conjugate represents possibly the simplest, but chemically and structurally most flexible, bio-nano conjugate. The [60] fullerene moiety provides the following attributes to the conjugate: a) precise three-dimensional architecture, b) a large hydrophobic mass, and c) unique electronic properties (17) . In contrast, the peptide component provides: a) structural diversity depending on the overall length and amino acids composition, b) charge flexibility, and c) secondary structure and recognition. There is also the potential that the presence of the hydrophobic [60]fullerene will modify the properties of the peptide and as such behavior unlike either of the component parts is possible.
The topic of [60]fullerene-peptide derivatives has been reviewed (17) (18) (19) (20) ; however, recent results have shown the versatility of both synthetic methods and applications, and suggest that a fresh view is warranted.
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Synthesis of C60-peptide conjugates
Using a preformed peptide
The direct reaction of a suitably functionalized peptide chain with C60 was first reported by Romanova et al. (21) . Using the high nucleophilicity of the primary amine in natural amino
Gly-L-Val) occurred via nucleophilic addition ( Figure 2 ). As an alternative, Wang et al. (22) showed that methyl glycylglycinate (H-Gly2-OMe) reacted via a nitrene intermediate (formed in the addition of Br2) with C60 to form the dipeptide derivative ( Figure 2 ). The use of a phase transfer overcame the issues associated with the low solubility of C60 in water.
The first [60]fullerene peptide was prepared by the reaction of a N-terminal free pentapeptide (Ala-Aib-Ala-Aib-Ala-OMe) with a methanofullerene through a linker based on a benzoic acid moiety ( Figure 3 ) (23) . Following this report a wide range of alternative linkage groups have been reported as being equally effective in facilitating the attachment of a preformed peptide (24) (25) (26) (27) (28) (29) (30) . Much of this work has been subject to recent reviews (17) (18) (19) (20) , and a selection of the [60]fullerene derivatives used are also shown in Figure 3 . One important route that was demonstrated with the immunomodulating peptide tuftsin (Thr-Lys-Pro-Arg) allowed for the covalent conjugate to be formed via either reaction with the amine or carboxylic acid termini (Figure 4 ), which provides a flexibility to attach further substituents.
Although it had been found that it is possible to insert a preformed [60]fullerene-amino acid into the center of a peptide during solid phase peptide synthesis (31) , an alternative approach was reported, by Aroua et al., using a bis-tert-butyl ester ( Figure 5 ) that was reacted with resin-supported peptide to give a fulleropeptide (32) . Of course the difference between this approach and that described below is that this method results in the same CO2H termination at both ends of the resulting peptide. Thus, the latter may be better described as two peptides located on the same [60]fullerene.
Simultaneous peptide synthesis
With this route, the goal is to synthesis a Figure 6 ). It is unknown why an apparently small difference in the linkage group makes such a big difference in the reactivity.
In order to study how the presence and position within the peptide sequence of the
[60]fullerene affects the structure and relative structural stability of the peptide's conformation, the sequences Glu-Ile-Ala-Gln-Leu-Glu-Tyr-Glu-Ile-Ser-Gln-Leu-Glu-Gln-NH2 (2HP) was prepared in which either Baa ( Figure 6 ) was added to the terminus (i.e., Baa-Glu-Ile-Ala-GlnLeu-Glu-Tyr-Glu-Ile-Ser-Gln-Leu-Glu-Gln-NH2) or tyrosine (Tyr) was replaced with Baa (i.e.,
Glu-Ile-Ala-Gln-Leu-Glu-Baa-Glu-Ile-Ser-Gln-Leu-Glu-Gln-NH2). In addition, Baa was added to the terminus of Glu-Ile-Ala-Gln-Leu-Glu-Tyr-Glu-Ile-Ser-Gln-Leu-Glu-Gln-Glu-IleGln-Ala-Leu-Glu-Ser-NH2 (3HP) (i.e., Baa-Glu-Ile-Ala-Gln-Leu-Glu-Tyr-Glu-Ile-Ser-GlnLeu-Glu-Gln-Glu-Ile-Gln-Ala-Leu-Glu-Ser-NH2) (31) . It was observed that the yield was lower and the purification more difficult when the [60]fullerene residue is within the sequence.
In addition to the facilitating of higher yields when the [60]fullerene derivative is at the end, rather than in the middle of the peptide sequence, it has also been observed that the further the [60]fullerene residue was placed from the polymer matrix solid support the higher the isolated yield, see Figure 7 Finally an interesting footnote, since peptide biosynthesis offers a potential alternative to SPPS, the concept of creating an amino acylated 5'-phospho-2'-deoxyribocytidylriboadenosine subunit containing a [60]fullerene amino acid (pdCpA-Baa) was attempted (37).
Unfortunately, no reaction was observed between the hydrophilic phospho-cytidine-phosphoadenosine subunit (pdCpA) and hydrophobic Baa possibly due to the steric bulk of the latter.
Structural effects
The Unlike the native peptide, the spectra for both fullero-peptides change distinctly in the presence of SDS micelles than of TFE (see Figure 9b and c). The shape of the spectrum for fullero-
changes in a manner consistent with the presence of an extended conformation (34) .
Although initial results suggested that the presence of a [60]fullerene substituent would change the relative stability of specific secondary structures, subsequent work showed that the
[60]fullerene could either promote a different structure or preclude a structural change (31) . For example while the parent peptide Glu-Ile-Ala-Gln-Leu-Glu-Tyr-Glu-Ile-Ser-Gln-Leu-GluGln-NH2 (2HP) adopts a random coil in aqueous solution, and is transformed via an α-helix to a β-sheet with decreasing pH, when the [60]fullerene amino acid Baa ( Figure 6 ) is on the terminus (i.e., Baa-Glu-Ile-Ala-Gln-Leu-Glu-Tyr-Glu-Ile-Ser-Gln-Leu-Glu-Gln-NH2) the β-sheet structure is observed at all pH values. In contrast, with the Baa in the middle of the peptide (i.e., Glu-Ile-Ala-Gln-Leu-Glu-Baa-Glu-Ile-Ser-Gln-Leu-Glu-Gln-NH2) the random coil converts to an α-helix with decreasing pH, but never to a β-sheet (31) . By contrast, the longer sequence Baa-Glu-Ile-Ala-Gln-Leu-Glu-Tyr-Glu-Ile-Ser-Gln-Leu-Glu-Gln-Glu-Ile-Gln-Ala-Leu-Glu-Ser-NH2 maintains an α-helix structure over all pH studied, while the parent is observed as a random coil in aqueous solution that converts to an α-helix with decreasing pH.
It is thus clear that while the [60]fullerene has a significant effect of secondary structure there is no consistent effect, and further study will be important.
It has been observed that while [60]fullerene-peptides are soluble in water they form aggregates, presumably as a consequence of the presence of both hydrophobic (C60) and hydrophilic (amino acid) groups within the same molecule (31) . The relative size of the aggregates is found to depend on the pH of the solution, but independent of concentration. The 
Antioxidant activity
The antioxidant activity C60 and its derivatives are well established, but low solubility and a tendency to aggregation are considered limiting factors of its application. The antioxidant assay of Baa ( Figure 6 ) and the derived peptide, Baa-(Glu)4-(Gly)3-Ser-OH were determined in comparison with Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), a commercially available potent antioxidant of the vitamin E family (31) . As may be seen from In a different study, the antioxidant capacity was measured by the ferrous ion oxidationxylenol orange (FOX) method for [60]fullerene peptidosteroid hybrids, Fp-GABA-Gly-GABA-OSt and Fp-GABA-GABA-Gly-GABA-OSt (Figure 11c and d, respectively) (29) . As may be seen from Figure 13 , there is significant improvement over vitamin C and C60 (29) . This was suggested to be associated with reduced aggregation and high solubility of the peptide derivatives.
Cellular uptake
The 
Toxicity and antimicrobial activity
The functionalization of C60 has the potential to provide greater interaction between the in the middle of the sequence. However, it was shown that the antimicrobial activity was most probably inherently due to the C60 rather than the specific sequence, since the fullero-peptide H-Gly-Orn-Gly-Fgu-Gly-Orn-Gly-NH 2 showed equal or better activity (34) . The presence of C60 itself is clearly not totally a prerequisite for antimicrobial activity since, in a study of a series of [60]fullerene peptide derivatives, tested using the broth microdilution method against
Staphylococcus aureus NCTC 6571 and Escherichia coli NCTC 10418, all the fullerenyl-based compounds were inactive, even at higher concentrations, with MIC greater than 100 to 340 (μg/mL) (28) .
Possibly the result that is both disappointing and promising at the same time, is a study 
Antibody recognition
As noted in the introduction, one of the attributes of a peptide is its ability to be recognized. patients' sera (ELISA experiment). In Table 1 , the reactivities of the [60]fullerene peptide are listed in comparison with the parent peptide in its free and C-terminal amide form.
While the [60]fullerene-peptide strongly recognizes anti-Sm/U1RNP specificities, it was also recognized by anti-Ro/La positive sera, which are negative to anti-Sm/U1RNP sera.
Most importantly, the parent [60]fullerene compound shows no recognition at all, suggesting that conversion of the carboxylic end of the parent peptide to an ester functionality in the
[60]fullerene peptide was responsible for the decrease in disease specificity.
Enzymatic inhibition and anti-HIV activity
Immunomodulating peptide tuftsin (Thr-Lys-Pro-Arg) derivatives of C60 ( Figure 11 ) were assayed for their stability against leucine aminopeptidase degradation and the immunostimulant activity to murine peritoneal macrophages were investigated in vitro (27) . Compared with the natural tuftsin, both [60]fullerene derivatives showed significant enhancement of phagocytosis, chemotaxis activities and major histocompatibility complex class II (MHC II) molecule expression. The two conjugates also exhibit complete resistance to enzymatic hydrolysis, and were found to be non-toxic to macrophages in the tested concentrations. These results suggested that the C60-tuftsin conjugates could be used as potential candidates of immune modulators and vaccine adjuvants (27) .
The active site of the HIV-1 protease (HIV-1 PR) is a quasi-spherical hydrophobic cavity, whose diameter is about 10 Å. In a landmark paper Friedman et al., suggested from computer graphics simulation, that the hydrophobic cleft of HIV-1 protease could perfectly host a C60 molecule (44) . If the interaction between the C60 and HIV-1 PR could be made sufficiently strong, inhibition of the catalytic activity would be expected. However, the problem of solubilizing C60 in a medium suitable for biological tests was initially an issue since it is insoluble in water. Given the solubility of [60]fullerene-peptide conjugates it was suggested that these would be ideal candidates for HIV-1 inhibition (24).
Unfortunately, initial results were unpromising. Anti-HIV-1 protease activities were conducted on using a [60]fullerene conjugate of the pentapeptide sequence H-Thr-Thr-AsnTyr-Thr-OH (Figure 17 ), since this sequence is a known activator of human monocyte chemotaxis; however, the activity was shown to be moderate (K i = 100 μM) (24) . Some promise was given since the [60]fullerene-peptide activity was elevated compared to the underivatized peptide.
In an effort to narrow the plethora of possible "C60 fragment" and "peptide sequence"
combinations an in silico drug screening approach was investigated (45) . A database was created from a range of C60 derivatives and their binding scores with HIV-1 PR were computed using docking techniques, and compared with biological tests with purified HIV-1 PR. It was interesting that experimental results confirm the binding scores predicted from the docking calculations. From this data it was found that Fmoc-Baa (c.f. Figure 6 ) had about three times better inhibitory binding (Ki = 36 nM) than the most active [60]fullerene-based inhibitor (Ki = 103 nM) reported at that time (45) . The calculations also suggested that the presence of the 9-fluorenylmethoxycarbonyl (Fmoc) protecting group on the [60]fullerene-substituted phenylalanine (i.e., Fmoc-Baa) improved the inhibition dramatically as compared to the corresponding free amino acid (Baa, Figure 6 ) because of a favorable interactions with the hydrophobic binding pocket (45) . In order to determine if improved binding was possible through the incorporation of a designer peptide tail, a series of [60]fullerene amino acid derived peptides were prepared (37) . In this case the terminal amino acid, Phe(4-aza-C60)-OH, was derived from the dipolar addition to C60 of the Fmoc-N-protected azido amino acids derived from phenylalanine (16) .
The rationale for the design of three peptide models was based on the structure of HIV-1 PR itself. It was hypothesized that an oligo-Lys peptide tail (Figure 18a ) would provide both the positive charges and enough flexibility for the electrostatic interaction to occur (45) . The knowledge that HIV-1 PR can recognize a Phe-Pro dipeptide subunit was the rationale for choosing a Pro-Hyp-Lys sequence (Figure 18b) , and the Hyp-Hyp-Lys sequence (Figure 18c) was chosen because the addition of the second OH group present on Hyp (as compared to Pro) allows another opportunity for H-bonding (37) . The position of the [60]fullerene peptides into the active site were determined in silico ( Figure 19 ) and compared to the binding 
Transdermal effects
The ability of nanomaterials (such as quantum dots and fullerenes) to penetrate intact skin (47, 48) can be either a concern with regard to toxicity or provide a route for drug delivery.
Given that the addition of a [60]fullerene-derived amino acid to a cationic peptide results in the peptide showing cellular uptake, whereas the same peptide sequence in the absence of Baa shows no transport across the cell membrane (36) , it was logical to investigate whether the same 
Conclusions
The recent work on [60]fullerene-peptides has shown their potential application across a wide range of applications. Some of these are expected, such as their antioxidant properties.
However, the ability of the C60 moiety to facilitate cellular uptake and transdermal transport where the analogous parent peptides show no propensity, demonstrates the new chemistry observed for the conjugate as compared to the components. The understanding of the effects of such a compact superhydrophobic moiety within a biological system is only now being explored, and the use of computer simulation offers a real opportunity to screen many possible structures. confocal-differential interference contrast (DIC) channel image shows an intact stratum corneum (SC) and underlying epidermal (E) and dermal layers (D). Middle row: Baa-
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